193 related articles for article (PubMed ID: 10593354)
1. Medical treatment of later-stage motor problems of Parkinson disease.
Ahlskog JE
Mayo Clin Proc; 1999 Dec; 74(12):1239-54. PubMed ID: 10593354
[TBL] [Abstract][Full Text] [Related]
2. [Treatment in Parkinson disease].
Takáts A
Orv Hetil; 2004 Apr; 145(15):833-4. PubMed ID: 15188639
[No Abstract] [Full Text] [Related]
3. Current pharmacotherapeutic treatment options in Parkinson's disease.
Rezak M
Dis Mon; 2007 Apr; 53(4):214-22. PubMed ID: 17586328
[TBL] [Abstract][Full Text] [Related]
4. Other pharmacological treatments for motor complications and dyskinesias.
Waters C
Mov Disord; 2005; 20 Suppl 11():S38-44. PubMed ID: 15822104
[TBL] [Abstract][Full Text] [Related]
5. Understanding Parkinson's disease: an update on current diagnostic and treatment strategies.
Pahwa R
J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):4-10. PubMed ID: 17948613
[TBL] [Abstract][Full Text] [Related]
6. [COMT inhibitors].
Bornkessel B
Med Monatsschr Pharm; 1999 May; 22(5):138-41. PubMed ID: 10365553
[No Abstract] [Full Text] [Related]
7. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
Stocchi F; Rascol O; Kieburtz K; Poewe W; Jankovic J; Tolosa E; Barone P; Lang AE; Olanow CW
Ann Neurol; 2010 Jul; 68(1):18-27. PubMed ID: 20582993
[TBL] [Abstract][Full Text] [Related]
8. 'Bad guys' among the antiparkinsonian drugs.
Pirtosek Z
Psychiatr Danub; 2009 Mar; 21(1):114-8. PubMed ID: 19270634
[TBL] [Abstract][Full Text] [Related]
9. Drugs for Parkinson's disease.
Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
Fung VS; Herawati L; Wan Y; ;
Mov Disord; 2009 Jan; 24(1):25-31. PubMed ID: 18846551
[TBL] [Abstract][Full Text] [Related]
11. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.
Ahlskog JE
Mayo Clin Proc; 2014 Jul; 89(7):997-1003. PubMed ID: 24996235
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
[TBL] [Abstract][Full Text] [Related]
13. COMT inhibition and safety.
Martignoni E; Blandini F; Pacchetti C; Nappi G
Funct Neurol; 2001; 16(4 Suppl):135-40. PubMed ID: 11996508
[No Abstract] [Full Text] [Related]
14. Parkinson's disease: drug therapy.
Oertel WH; Quinn NP
Baillieres Clin Neurol; 1997 Apr; 6(1):89-108. PubMed ID: 9426870
[TBL] [Abstract][Full Text] [Related]
15. [The use of Stalevo in Hungary for patients with Parkinson disease and its effect on the quality of life].
Klivényi P; Vécsei L
Ideggyogy Sz; 2008 Jan; 61(1-2):42-8. PubMed ID: 18372774
[TBL] [Abstract][Full Text] [Related]
16. [What strategies are recommended for early stage disease? Other treatments].
Damier P
Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():105-8. PubMed ID: 10916044
[No Abstract] [Full Text] [Related]
17. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
18. COMT inhibitors: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S45-51. PubMed ID: 12211139
[No Abstract] [Full Text] [Related]
19. Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease.
Nutt JG
Lancet; 1998 Apr; 351(9111):1221-2. PubMed ID: 9643737
[No Abstract] [Full Text] [Related]
20. New concepts in the treatment of Parkinson's disease.
Ahlskog JE; Wilkinson JM
Am Fam Physician; 1990 Feb; 41(2):574-84. PubMed ID: 1967895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
